Sdz 51641 | CAS#91456-99-4 | fatty acid oxidation inhibitor

MedKoo Cat#: 461965 | Name: Sdz 51641

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sdz 51641 is an inhibitor of fatty acid oxidation which is highly selective for the liver.

Chemical Structure

Sdz 51641

CAS#91456-99-4

Theoretical Analysis

MedKoo Cat#: 461965

Name: Sdz 51641

CAS#: 91456-99-4

Chemical Formula: C14H20O2

Exact Mass: 220.1463

Molecular Weight: 220.31

Elemental Analysis: C, 76.33; H, 9.15; O, 14.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Sdz 51641; 2-(1,1-Dimethylethyl)-2-(4-methylphenyl)-1,3-dioxolane

IUPAC/Chemical Name

1,3-Dioxolane, 2-(1,1-dimethylethyl)-2-(4-methylphenyl)-

InChi Key

KONLOUNOGLJAIE-UHFFFAOYSA-N

InChi Code

InChI=1S/C14H20O2/c1-11-5-7-12(8-6-11)14(13(2,3)4)15-9-10-16-14/h5-8H,9-10H2,1-4H3

SMILES Code

CC1=CC=C(C2(C(C)(C)C)OCCO2)C=C1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 220.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Vickers AE. Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors. Toxicol Pathol. 2009 Jan;37(1):78-88. doi:10.1177/0192623308329285. PubMed PMID: 19234235. 2: Vickers AE, Bentley P, Fisher RL. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices. Toxicol In Vitro. 2006 Oct;20(7):1173-82. Epub 2006 Mar 20. PubMed PMID: 16545538. 3: Young DA, Ho RS, Bell PA, Cohen DK, McIntosh RH, Nadelson J, Foley JE. Inhibition of hepatic glucose production by SDZ 51641. Diabetes. 1990 Nov;39(11):1408-13. PubMed PMID: 2227112.